10-Q: Allied Corp. Reports Net Loss of $1.7 Million in Q2 2024 Amidst Ongoing Financial Challenges

Allied Corp. faces continued financial strain, reporting a $1.7 million net loss in the second quarter of 2024, raising substantial doubt about its ability to continue as a going concern.

Summary

• Allied Corp. reported a net loss of $1,702,499 for the six months ended February 29, 2024.
• The company's revenue for the same period was $19,039, with a gross margin of $17,036.
• Total expenses for the six months ended February 29, 2024, were $1,719,535, down from $3,443,403 in the prior-year period.
• The company had a working capital deficit of $8,953,089 as of February 29, 2024.
• Allied Corp.'s ability to continue as a going concern is dependent on raising sufficient financing.
• The company plans to finance operations through equity sales, debt financing, and related-party loans.

Sentiment

Score: 2

Explanation: The company is facing significant financial challenges, including a large net loss, working capital deficit, and defaults on convertible notes, indicating a negative outlook.

Positives

• The company has reduced operating expenses compared to the same period last year, from $3,219,382 to $1,533,643.
• The company has successfully amended the maturity dates of its convertible notes to December 31, 2024.

Negatives

• The company reported a significant net loss of $1,702,499 for the six months ended February 29, 2024.
• Revenue decreased from $69,625 to $19,039 compared to the same period last year.
• The company has a substantial working capital deficit of $8,953,089.
• The company has defaulted on multiple convertible notes.
• There is substantial doubt about the company's ability to continue as a going concern.

Risks

• The company's ability to continue as a going concern is dependent on its ability to raise sufficient financing.
• There is no assurance that financing will be available in amounts or terms acceptable to the company.
• The company faces liquidity risk due to its working capital deficit and may not be able to meet its financial obligations.
• The company is exposed to credit risk on its cash accounts held with major banks.
• The company is exposed to foreign currency risk due to transactions denominated in Canadian dollars and Colombian Pesos.
• The company is involved in a legal proceeding related to the acquisition of a Nevada state cannabis license and a building seizure.
• Changes in the enforcement policy of the federal government with respect to current federal laws applicable to cannabis could cause significant financial damage to the company.

Future Outlook

The company's future depends on its ability to raise capital and achieve profitability, with plans to finance operations through equity sales and debt financing.

Management Comments

• Allied Corp. is committed to building and maintaining strong relationships with its partners and customers around the world.
• The company is dedicated to meeting the evolving needs of patients and healthcare professionals with its high-quality medical cannabis products.

Industry Context

Allied Corp. operates in the medical cannabis industry, focusing on the development and production of cannabinoid health solutions. The industry is subject to evolving regulations and faces challenges related to legalization, market acceptance, and competition.

Comparison to Industry Standards

• The average cost of cannabis production in North America is approximately $1.00 to $2.00 per gram.
• Allied Corp. believes its anticipated direct agricultural cost of raw flower in Colombia to be in the range of $0.05 to $0.075 per gram.
• This cost advantage is expected to provide a competitive advantage in the international market, however no revenue has yet been generated from this market to support this claim.
• Many companies in the cannabis industry are experiencing net losses, similar to Allied Corp. For example, Canopy Growth Corporation reported a net loss of $266.7 million CAD in its most recent quarterly report, Aurora Cannabis Inc. reported a net loss of $67.2 million CAD, and Tilray Brands, Inc. reported a net loss of $61.6 million USD.

Management Changes

Legal Proceedings

• The company is involved in a legal proceeding related to the acquisition of a Nevada state cannabis license and a building seizure.
• The company filed a complaint seeking injunctive relief or money damages.
• A status conference was held, and the court suggested proceeding with litigation.

Related Party Transactions

• As of February 29, 2024, the company had $942,892 payable to related parties, including the CEO, COO, CFO, Chief Business Development Officer, and a director.
• The transactions were for expenses paid on behalf of the company and advances received.

Stakeholder Impact

• Shareholders: Potential dilution from equity financing and uncertainty about the company's future.
• Employees: Uncertainty about job security due to the company's financial challenges.
• Creditors: Risk of non-payment due to the company's working capital deficit and defaults on convertible notes.
• Suppliers: Potential impact on payment terms and future business relationships.
• Customers: Potential impact on product availability and quality.

Next Steps

• The company needs to raise significant additional capital to fund its plan of operations.
• The company will continue to evaluate its plan of operations to determine the most effective use of its limited cash resources.
• The company will proceed with litigation related to the Nevada state cannabis license and building seizure.

Key Dates

Keywords

medical cannabis, cannabinoid health solutions, cannabis production, Colombia, cannabis licenses, international distribution, financial deficit, convertible notes, equity financing, going concern